Contract Sales For 503b Outsourcing & Wholesale Distribution
Founded in 2014, Severna's mission has been to service hospitals, clinics & healthcare systems across the US with strategic pharmaceutical and medical device supply chain solutions to overcome disruption and ongoing specialty needs. Through rigorous Quality Systems, Severna Health works to identify, inspect, and match high quality products with Severna clients. Whether a Severna Health product, or a Severna Health vetted regulatory compliant supplier, Severna will work to problem solve supply chain disruption with long term solutions.
Severna Health is a SAM certified small business registered and established with the Federal Food and Drug Administration as a Specification Developer and Repackager. Severna Health has multiple ongoing FDA 510k fillings and manufacturer direct partnerships to provide additional ongoing solutions to critically disrupted Pharmaceuticals, Medical Devices and Supplies.
What We Do:
A reliable source for medical device and PPE procurement
Severna Health was formed in 2014 to address continual supply chain disruption felt by hospitals and large healthcare systems nationwide. With a diversified focus on pharmaceuticals, various surgical supplies and medical devices, and now Personnel Protective Equipment (PPE), Severna Health is a trustworthy company, uniquely positioned to provide reliable solutions. We specialize in manufacturing and distributing certified products to state departments, healthcare providers, and hospitals nationwide, all up to government standards as well as offering various FDA consulting services. We are well known for our high-quality products and prompt and reliable services.
Gel & Clot Activator For Human Blood Testing
Gel & Clot Activator tubes offer serum for determinations in chemistry and serology. The gel is very stable in physical and chemical features. After centrifugation, the gel can effectively separate the serum. So, serum could be aspirated directly from the collection tube, no need to transfer to another container.
Citrate concentration of either 0.109M (3.2 %) or 0.129M (3.8 %) is available. The mixing ratio is
1 part citrate to 9 parts blood.
Nitrile Latex Gloves
Severna Health solely sources its Nitrile Gloves direct from the manufacturer and is an Authorized Distributor for the Nitrilium, A+ & SevernaHealth400 Chemotherapy rated brands.
Not all nitrile gloves are created equal – Nitrile gloves are currently being marketed and sold to a vast number of product specifications. It is important to understand the differences and what best protects the end users given the particular tasks they may be performing. Each of the brands Severna Health represents meet stringent chemotherapy specifications with superior permeation rates to competitive options. A true 4mil glove with 5mil textured fingertips, medical workers can feel a pulse with maximum protection against exposure.
Since the beginning of the pandemic, Severna Health has been working with multiple manufacturers and distributors of COVID-19 tests. From PCR, Rapid Antigen, and Antibody tests, Severna can assist in determining what the best option is for your specific need or use.
Severna Health understands current market conditions and prides itself on providing viable solutions with timely deliverables at favorable price points. Furthermore, Severna Health works tirelessly to ensure all products are FDA or CE-compliant and shipped with a full chain of custody.
Our disposable, 3-ply surgical/medical masks are designed to provide 3 layers of protection against bacteria, viruses, and other large droplets or bodily fluids while also being comfortable to wear and breathable. Our N95 masks provide a very close facial fit and very efficient filtration of airborne particles and are most commonly used in medical settings. All of our face masks are available to you in either bulk through our wholesale purchasing or in smaller sample packages on this site.More Details
Proven strategies with the ability and relationships to make them happen.
Healthcare providers need more than single-source providers. Through a comprehensive Quality Assurance Quality Control (QAQC) review process, Severna Health thoroughly inspects 503b vendors to help hospitals, clinics, and healthcare facilities navigate an ever-changing landscape of 503b outsourcing.
Severna Health operates on the frontlines with hospital pharmacy directors and buyers to resolve supply chain disruption through careful product selection criteria and vendor identification with a primary focus on 503b compound & wholesale distribution. Since the very inception of FDA 503b, Severna’s mission has been to assist our healthcare clients in making confident well-educated buying decisions while providing a single point of contact for all Severna-approved 503b suppliers. Current areas of concentration are DEA Class I, II & III Controls, IV bags, Syringe suites, and specialty vial compounds serving OR & ER, Oncology, Urology, Ophthalmic & wellness Departments.
Years of Experience
Our experience makes the difference.
As an FDA-registered and established specification developer and repackager, Severna Health is constantly exploring partnership opportunities for FDA product filings (NDA, ANDA & 510k) and facility development. Severna has internal FDA consultants, and 3rd party strategic partners capable of handling facility development and/or Quality Systems implementation/maintenance, as well as FDA product-specific filings. With existing distribution channels, Severna Health can assist with product sales and marketing, further enhancing any partnership opportunities.
Focused on addressing drug, testing, and equipment shortages, Severna Health works to improve supply chain deficiencies. Our pharmaceutical candidates are based on existing, well-known active pharmaceutical ingredients (APIs). With established mechanisms of action, safety profiles, and therapeutic activity, we avoid the risks of clinical development and regulatory approval. Our PPE and testing products are American-made. Severna health has multiple FDA 510K filings for nitrile gloves and are actively pursuing additional filings for critically disrupted medical devices.
For more information on Severna Health services and opportunities please contact us.
As a founding member, Scott’s responsibilities focus on business strategy & business plan execution. Scott currently serves as the Chief Executive Officer of Severna Health and Severna Laboratories, an FDA registered repackager & specification developer servicing FDA regulated pharmaceutical & medical device manufacturing, 503B Compounding & Wholesale Distribution. Since founding Severna in 2014, the Company has experienced significant expansion and year-over-year growth.
Before founding Severna, Scott served as Executive Vice President of an FDA regulated 503B Outsourcing Facility, Bryce Laboratories, Inc. Scott’s primary focus was to accelerate growth through a concentration of quality assurance, compliance, product control, & industry diversification.
Scott began his career with American Express Financial Advisors, before becoming Area Manager of Operations for AppleOne, Inc., and later Vice President of Business Development & Account Management for BrainBox Enterprises, Inc., where he oversaw marketing & strategic growth plans for clients such as Magellan Health, Discovery Health, Shire Pharmaceuticals, etc.
Scott has a Bachelor's degree from Hobart College. He and his wife Shannon reside in Annapolis, MD with their two children.
As a founding member, Matt’s responsibilities will focus on sales plan development & execution. Matt currently serves as Chief Revenue Officer of Severna Health, where he is responsible for the day to day sales & performance for Severna. In its sixth year of operations, Matt has Severna pacing to capacity in 2020.
Prior to Severna, Matt was the Executive Vice President of Sales for Pharmagen, Inc., a publicly held Pharmaceutical company focused on the nation’s sterile injectable shortage through independent wholesale distribution & pharmaceutical compounding/ADMIX.
Matt was instrumental in growing two pharmaceutical wholesalers, Global Pharmaceutical Sourcing (GPS) and Premium Rx National (PRN). At GPS, Matt developed the sales infrastructure, training program, and compensation plans while recruiting, hiring, and training 34 representatives generating $81 million in gross revenue within the first five years of operations. Matt’s success at PRN resulted in generated revenues from zero to $14 million within the first twelve months of operation.
Matt is a graduate of the University of Maryland, College Park, with a Bachelor of Arts in Communications. He and his wife reside in Annapolis, MD with their two children.